Usefulness of Cytokine Gene Polymorphisms for the Therapeutic Choice in Japanese Patients with Rheumatoid Arthritis

References

• Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376(9746):1094–1108. doi:10.1016/S0140-6736(10)60826-4
   PubMed Web of Science ®Google Scholar
• Bax M, van Heemst J, Huizinga TWJ, Toes REM. Genetics of rheumatoid arthritis: what have we learned? Immunogenetics. 2011;63(8):459–466. doi:10.1007/s00251-011-0528-6
   PubMed Web of Science ®Google Scholar
• Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum. 2008;58(10):3009–3019. doi:10.1002/art.23936
   PubMed Web of Science ®Google Scholar
• Bartold PM, Marino V, Cantley M, Haynes DR. Effect of porphyromonas gingivalis-induced inflammation on the development of rheumatoid arthritis. J. Clin Periodontol. 2010;37(5):405–411. doi:10.1111/j.1600-051X.2010.01552.x
   PubMed Web of Science ®Google Scholar
• Reichert S, Haffner M, Keyeβer G, et al. Detection of oral bacterial DNA in synovial fluid. J Clin Periodontol. 2013;40(6):591–598. doi:10.1111/jcpe.12102
   PubMed Web of Science ®Google Scholar
• Ogrendik M. Rheumatoid arthritis is an autoimmune disease caused by periodontal pathogens. Int J Gen Med. 2013;6:383–386. doi:10.2147/IJGM.S45929
   PubMedGoogle Scholar
• Takayanagi H. Osteoimmunology and the effects of the immune system on bone. Nat Rev Rheumatol. 2009;5(12):667–676. doi:10.1038/nrrheum.2009.217
   PubMed Web of Science ®Google Scholar
• Noack M, Miossec P. Selected cytokine pathways in rheumatoid arthritis. Semin Immunopathol. 2017;39(4):365–383.
   PubMed Web of Science ®Google Scholar
• Nishimura K, Sugiyama D. Meta-analysis: diagnostic accuracy of anti-cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Intern Med. 2007;146(11):797–808. doi:10.7326/0003-4819-146-11-200706050-00008
   PubMed Web of Science ®Google Scholar
• Ingegnoli F, Castelli R, Gualtierotti R. Rheumatoid factors: clinical applications. Dis Markers. 2013;35(6):727–734. doi:10.1155/2013/726598
   PubMed Web of Science ®Google Scholar
• Syversen SW, Gaarder PI, Goll GL. High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis. 2008;67(2):212–217. doi:10.1136/ard.2006.068247
   PubMed Web of Science ®Google Scholar
• Mouterde G, Rincheval N, Lukas C, et al. Outcome of patients with early arthritis without rheumatoid factor and ACPA and predictors of rheumatoid arthritis in the ESPOIR cohort. Arthritis Res Ther. 2019;21(1):140. doi:10.1186/s13075-019-1909-8
   PubMed Web of Science ®Google Scholar
• Scherer HU, Huizinga TWJ, Krönke G, Schett G, Toes REM. The B cell response to citrullinated antigens in the development of rheumatoid arthritis. Nat Rev Rheumatol. 2018;14(3):157–169. doi:10.1038/nrrheum.2018.10
   PubMed Web of Science ®Google Scholar
• Ou Y, Yang Y, Xiang X, Wu Y. Relationship between the IL-10 (−1082 A/G) polymorphism and the risk of immune/idiopathic thrombocytopenic purpura: a meta-analysis. Cytokine. 2020;125:154820. doi:10.1016/j.cyto.2019.154820
   PubMed Web of Science ®Google Scholar
• Ge L, Huang Y, Zhang H, Liu R, Xu N. Association between polymorphisms of interleukin 10 with inflammatory biomarkers in East Chinese Han patients with rheumatoid arthritis. Joint Bone Spine. 2015;82(3):182–186. doi:10.1016/j.jbspin.2014.11.007
   PubMed Web of Science ®Google Scholar
• Ciccacci C, Conigliaro P, Perricone C, et al. Polymorphisms in STAT-4, IL-10, PSORS1C1, PTPN2 and MIR146A genes are associated differently with prognostic factors in Italian patients affected by rheumatoid arthritis. Clin Exp Immunol. 2016;186(2):157–163. doi:10.1111/cei.12831
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Murasawa A, Ito S, et al. Cytokine gene polymorphisms associated with rheumatoid arthritis and periodontitis in Japanese adults. J Periodontol. 2009;80(5):792–799. doi:10.1902/jop.2009.080573
   PubMed Web of Science ®Google Scholar
• Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev. 2008;226(1):205–218. doi:10.1111/j.1600-065X.2008.00706.x
   PubMed Web of Science ®Google Scholar
• Tian G, Li JL, Wang DG, Zhou D. Targeting IL-10 in auto-immune diseases. Cell Biochem Biophys. 2014;70(1):37–49. doi:10.1007/s12013-014-9903-x
   PubMed Web of Science ®Google Scholar
• Cush JJ, Splawski JB, Thomas R, et al. Elevated interleukin-10 levels in patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):96–104. doi:10.1002/art.1780380115
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Otsuka T, Hotokebuchi T, et al. Effect of IL-10 on collagen-induced arthritis in mice. Inflamm Res. 1996;45(6):283–288. doi:10.1007/BF02280992
   PubMed Web of Science ®Google Scholar
• Whalen JD, Lechman EL, Carlos CA, et al. Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. J Immunol. 1999;162(6):3625–3632.
   PubMed Web of Science ®Google Scholar
• Jahid M, Ul-Haq R, Avasthi R, et al. Interleukin10-1082 A/G polymorphism: allele frequency, correlation with disease markers, messenger RNA and serum levels in north Indian rheumatoid arthritis patients. Clin Biochem. 2018;55:80–85. doi:10.1016/j.clinbiochem.2018.03.024
   PubMed Web of Science ®Google Scholar
• Ates O, Hatemi G, Hamuryudan V, et al. Tumor necrosis factor-alpha and interleukin-10 gene promoter polymorphisms in turkish rheumatoid arthritis patients. Clin Rheumatol. 2008;27(10):1243–1248. doi:10.1007/s10067-008-0893-1
   PubMed Web of Science ®Google Scholar
• Speziani C, Rivollier A, Gallois A, et al. Murine dendritic cell transdifferentiation into osteoclasts is differentially regulated by innate and adaptive cytokines. Eur J Immunol. 2007;37(3):747–757. doi:10.1002/eji.200636534
   PubMed Web of Science ®Google Scholar
• Takayanagi H, Ogasawara K, Hida S, et al. T cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature. 2000;408(6812):600–605. doi:10.1038/35046102
   PubMed Web of Science ®Google Scholar
• Khani-Hanjani A, Lacaille D, Hoar D, et al. Association between dinucleotide repeat in non-cording region of interferon-gamma gene and susceptibility to, and severity of, rheumatoid arthritis. Lancet. 2000;356(9232):820–825. doi:10.1016/S0140-6736(00)02657-X
   PubMed Web of Science ®Google Scholar
• Pokorny V, McLean L, McQueen F, Abu-Maree M, Yeoman S. Interferon-gamma microsatellite and rheumatoid arthritis. Lancet. 2001;358(9276):122–123. doi:10.1016/S0140-6736(01)05342-9
   PubMed Web of Science ®Google Scholar
• Constantin A, Navaux F, Lauwers-Cancès V, et al. Interferon gamma gene polymorphism and susceptibility to, and severity of, rheumatoid arthritis. Lancet. 2001;358(9298):2051–2052. doi:10.1016/S0140-6736(01)07143-4
   PubMed Web of Science ®Google Scholar
• Angelo HD, Gomes Silva II, Oliveira RD, et al. Interleukin-18, interleukin-12B and interferon-γ gene polymorphisms in Brazilian patients with rheumatoid arthritis: a pilot study. Tissue Antigens. 2015;86(4):276–278. doi:10.1111/tan.12645
   PubMedGoogle Scholar
• Lee YH, Bae SC. Association between interferon-γ +874 T/A polymorphism and susceptibility to autoimmune diseases: a meta-analysis. Lupus. 2016;25(7):710–718. doi:10.1177/0961203315624557
   PubMed Web of Science ®Google Scholar
• Teker E, Akadam-Teker AB, Ozturk O, et al. Association between the interferon gamma 874 T/A polymorphism and severity of valvular damage in patients with rheumatic heart disease. Biochem Genet. 2018;56(3):225–234. doi:10.1007/s10528-017-9839-0
   PubMed Web of Science ®Google Scholar
• Letterio JJ, Roberts AB. Regulation of immune responses by TGF-β. Annu Rev Immunol. 1998;16(1):137–161. doi:10.1146/annurev.immunol.16.1.137
   PubMed Web of Science ®Google Scholar
• Gualtierotti R, Biggioggero M, Penatti AE, Meroni PL. Updating on the pathogenesis of systemic lupus erythematosus. Autoimmun Rev. 2010;10(1):3–7. doi:10.1016/j.autrev.2010.09.007
   PubMed Web of Science ®Google Scholar
• Su DL, Lu ZM, Shen MN, et al. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol. 2012;2012:347141. doi:10.1155/2012/347141
   PubMed Web of Science ®Google Scholar
• Komai T, Okamura T, Yamamoto K, Fujio K. The effects of TGF-βs on immune responses. Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(1):51–58. doi:10.2177/jsci.39.51
   PubMedGoogle Scholar
• Shull MM, Ormsby I, Kier AB. Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease. Nature. 1992;359(6397):693–699. doi:10.1038/359693a0
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC. Association between circulating transforming growth factor-β1 level and polymorphisms in systemic lupus erythematosus and rheumatoid arthritis: a meta-analysis. Cell Mol Biol (Noisy-Le-Grand). 2017;63(1):53–59. doi:10.14715/cmb/2017.63.1.11
   PubMed Web of Science ®Google Scholar
• Alayli G, Kara N, Tander B, et al. Association of transforming growth factor beta1 gene polymorphism with rheumatoid arthritis in a Turkish population. Joint Bone Spine. 2009;76(1):20–23. doi:10.1016/j.jbspin.2008.02.012
   PubMed Web of Science ®Google Scholar
• Jančić I, Šefik-Bukilica M, Živojinović S, et al. Influence of promoter polymorphisms of the TNF-α (−308G/A) and IL-6 (−174G/C) genes on therapeutic response to etanercept in rheumatoid arthritis. J Med Biochem. 2015;34(4):414–421. doi:10.2478/jomb-2014-0060
   PubMed Web of Science ®Google Scholar
• Rodríguez-Carrio J, Alperi-López M, López P, et al. TNFα polymorphism as marker of immunosenescence for rheumatoid arthritis patients. Exp Gerontol. 2015;61:123–129. doi:10.1016/j.exger.2014.12.009
   PubMed Web of Science ®Google Scholar
• De Simone C, Farina M, Maiorino A, et al. TNF-alpha gene polymorphisms can help to predict response to etanercept in psoriatic patients. J Eur Acad Dermatol Venereol. 2015;29(9):1786–1790. doi:10.1111/jdv.13024
   PubMed Web of Science ®Google Scholar
• Schotte H, Schlüter B, Schmidt H, et al. Putative IL-10 low producer genotypes are associated with a favourable etanercept response in patients with rheumatoid arthritis. PLoS One. 2015;10(6):e0130907. doi:10.1371/journal.pone.0130907
   PubMed Web of Science ®Google Scholar
• Lee YH, Bae SC, Song GG. Functional FCGR3A 158 V/F and IL-6-174 C/G polymorphisms predict response to biologic therapy in patients with rheumatoid arthritis: a meta-analysis. Rheumatol Int. 2014;34(10):1409–1415. doi:10.1007/s00296-014-3015-1
   PubMed Web of Science ®Google Scholar
• Mateen S, Zafar A, Moin S, Khan AQ, Zubair S. Understanding the role of cytokines in the pathogenesis of rheumatoid arthritis. Clin Chim Acta. 2016;455:161–171. doi:10.1016/j.cca.2016.02.010
   PubMed Web of Science ®Google Scholar